We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
(+30%)
Cap. Flow
+$3.05B
Cap. Flow
% of AUM
16.07%
Top 10 Holdings %
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$492M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$263M |
| 3 |
Qualcomm
QCOM
|
+$143M |
| 4 |
Broadcom
AVGO
|
+$118M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$81.8M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$18.6M |
| 3 |
Chevron
CVX
|
+$11.9M |
| 4 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$10.9M |
| 5 |
ExxonMobil
XOM
|
+$8.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.28% |
| 2 | Financials | 15.39% |
| 3 | Healthcare | 5.04% |
| 4 | Energy | 4.05% |
| 5 | Consumer Discretionary | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Dollar Tree
DLTR
$24.4B
| $5.54M | 0.03% |
39,391
-19,493
| -33% | -$2.37M |
|
352
Acadia Pharmaceuticals
ACAD
$4.43B
| $5.53M | 0.03% |
236,898
+43,230
| +22% | +$869K |
|
353
Natera
NTRA
$38.3B
| $5.51M | 0.03% |
58,979
+33,045
| +127% | +$3.43M |
|
354
BioMarin Pharmaceuticals
BMRN
$11.6B
| $5.49M | 0.03% |
62,117
+22,161
| +55% | +$1.83M |
|
355
Zentalis Pharmaceuticals
ZNTL
$337M
| $5.48M | 0.03% |
65,199
+27,611
| +73% | +$2.14M |
|
356
Iovance Biotherapeutics
IOVA
$1.82B
| $5.45M | 0.03% |
285,506
+148,649
| +109% | +$3.27M |
|
357
Insmed
INSM
$21.4B
| $5.44M | 0.03% |
199,817
+85,043
| +74% | +$2.43M |
|
358
Paycom
PAYC
$7.64B
| $5.44M | 0.03% |
13,101
+1,463
| +13% | +$693K |
|
359
Denali Therapeutics
DNLI
$3.65B
| $5.43M | 0.03% |
121,755
+61,394
| +102% | +$2.91M |
|
360
Alnylam Pharmaceuticals
ALNY
$27.5B
| $5.42M | 0.03% |
31,945
+15,515
| +94% | +$2.88M |
|
|
WBA
361
DELISTED
Walgreens Boots Alliance
WBA
| $5.42M | 0.03% |
103,851
-387
| -0.4% | -$18.7K |
|
362
Kodiak Sciences
KOD
$2.6B
| $5.41M | 0.03% |
63,753
+31,429
| +97% | +$3.2M |
|
363
Trimble
TRMB
$13.2B
| $5.4M | 0.03% |
61,978
+8,011
| +15% | +$688K |
|
364
Travere Therapeutics
TVTX
$5.2B
| $5.38M | 0.03% |
173,286
+73,364
| +73% | +$2.07M |
|
365
American Electric Power
AEP
$69.6B
| $5.38M | 0.03% |
60,440
-7,871
| -12% | -$664K |
|
366
Builders FirstSource
BLDR
$7.15B
| $5.37M | 0.03% |
62,669
-4,008
| -6% | -$272K |
|
367
FNB Corp
FNB
$6.73B
| $5.36M | 0.03% |
442,134
+17,980
| +4% | +$217K |
|
|
DCPH
368
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.35M | 0.03% |
547,997
+482,080
| +731% | +$9.07M |
|
369
Western Digital
WDC
$188B
| $5.34M | 0.03% |
108,425
+22,322
| +26% | +$970K |
|
|
KRTX
370
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.32M | 0.03% |
40,603
+14,433
| +55% | +$1.87M |
|
|
VXRT
371
DELISTED
Vaxart
VXRT
| $5.32M | 0.03% |
847,774
+492,066
| +138% | +$3.36M |
|
372
Cintas
CTAS
$81.9B
| $5.3M | 0.03% |
47,864
-6,496
| -12% | -$700K |
|
|
VERV
373
DELISTED
Verve Therapeutics
VERV
| $5.29M | 0.03% |
+143,374
| New | +$6.02M |
|
|
AGEN
374
Agenus
AGEN
$312M
| $5.27M | 0.03% |
83,438
+59,013
| +242% | +$4.65M |
|
375
Costco
COST
$422B
| $5.25M | 0.03% |
9,254
-1,969
| -18% | -$1.01M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.
- Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
- Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
- Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
- Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
- Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.
Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.